The Kv7/KCNQ channel blocker XE991 protects nigral dopaminergic neurons in the 6-hydroxydopamine rat model of Parkinson's disease.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Brain Research Bulletin

• Publication date

  2018-03-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.brainresbull.2017.11.011PMID 29174294
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Old and new challenges in Parkinson's disease therapeutics

  2017cited by this paper
• Brain Iron Metabolism Dysfunction in Parkinson’s Disease

  2017cited by this paper
• The two-century journey of Parkinson disease research

  2017cited by this paper
• Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's disease

  2016cited by this paper
• Activation of ATP-sensitive potassium channels enhances DMT1-mediated iron uptake in SK-N-SH cells in vitro

  2016cited by this paper
• Lesion of medullary catecholaminergic neurons is associated with cardiovascular dysfunction in rotenone‐induced Parkinson's disease rats

  2015cited by this paper
• Bee Venom Alleviates Motor Deficits and Modulates the Transfer of Cortical Information through the Basal Ganglia in Rat Models of Parkinson’s Disease

  2015cited by this paper
• Kv4 channel blockade reduces motor and neuropsychiatric symptoms in rodent models of Parkinson's disease.

  2015cited by this paper
• Intranigral administration of substance P receptor antagonist attenuated levodopa-induced dyskinesia in a rat model of Parkinson's disease.

  2015cited by this paper
• Protective Role of Kv7 Channels in Oxygen and Glucose Deprivation-Induced Damage in Rat Caudate Brain Slices

  2015cited by this paper
• SK channel blockade reverses cognitive and motor deficits induced by nigrostriatal dopamine lesions in rats.

  2014cited by this paper
• he effects of unilateral 6-OHDA lesion in medial forebrain bundle on he motor , cognitive dysfunctions and vulnerability of different triatal interneuron types in rats

  2014cited by this paper
• Triple Cysteine Module within M-Type K+ Channels Mediates Reciprocal Channel Modulation by Nitric Oxide and Reactive Oxygen Species

  2013cited by this paper
• Peptide hormone ghrelin enhances neuronal excitability by inhibition of Kv7/KCNQ channels

  2013cited by this paper
• The M‐current inhibitor XE991 decreases the stimulation threshold for long‐term synaptic plasticity in healthy mice and in models of cognitive disease

  2011cited by this paper
• Novel role of KCNQ2/3 channels in regulating neuronal cell viability

  2011cited by this paper
• M-type channels selectively control bursting in rat dopaminergic neurons

  2010cited by this paper
• Up-regulation of divalent metal transporter 1 in 6-hydroxydopamine intoxication is IRE/IRP dependent

  2010cited by this paper
• Emerging roles for G protein-gated inwardly rectifying potassium (GIRK) channels in health and disease

  2010cited by this paper
• Substantia nigra control of basal ganglia nuclei.

  2009cited by this paper
• Striatal and extrastriatal dopamine in the basal ganglia: An overview of its anatomical organization in normal and Parkinsonian brains

  2008cited by this paper
• Involvement of KCNQ2 subunits in [3H]dopamine release triggered by depolarization and pre‐synaptic muscarinic receptor activation from rat striatal synaptosomes

  2007cited by this paper
• The neuronal KCNQ channel opener retigabine inhibits locomotor activity and reduces forebrain excitatory responses to the psychostimulants cocaine, methylphenidate and phencyclidine.

  2007cited by this paper
• Myricetin reduces 6-hydroxydopamine-induced dopamine neuron degeneration in rats

  2007cited by this paper
• The KCNQ Channel Opener Retigabine Inhibits the Activity of Mesencephalic Dopaminergic Systems of the Rat

  2006cited by this paper
• A vital role for voltage-dependent potassium channels in dopamine transporter-mediated 6-hydroxydopamine neurotoxicity.

  2006cited by this paper
• Housing, husbandry and handling of rodents for behavioral experiments

  2006cited by this paper
• Neuroprotective effects of iron chelator Desferal on dopaminergic neurons in the substantia nigra of rats with iron-overload.

  2006cited by this paper
• Characterization of M-current in ventral tegmental area dopamine neurons.

  2006cited by this paper
• Histological, behavioural and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson's disease.

  2005cited by this paper
• Time Dependent Effects of 6-OHDA Lesions on Iron Level and Neuronal Loss in Rat Nigrostriatal System

  2004cited by this paper
• Multiple Channel Interactions Explain the Protection of Sympathetic Neurons from Apoptosis Induced by Nerve Growth Factor Deprivation

  2002cited by this paper
• Normotonic cell shrinkage because of disordered volume regulation is an early prerequisite to apoptosis.

  2000cited by this paper
• Functional changes of the basal ganglia circuitry in Parkinson's disease.

  2000cited by this paper
• A Primary Role for K+ and Na+ Efflux in the Activation of Apoptosis*

  1997cited by this paper
• Responses to cortical injury: I. Methodology and local effects of contusions in the rat.

  1981cited by this paper

• Symptomatic Vitamin and Nutrient Deficiencies of Autism Spectrum Disorder and the Potential for Treatment.

  2026cites this paper
• Increased KCNQ3 expression in papillary thyroid cancer promotes proliferation and migration

  2025cites this paper
• L-DOPA reverses the impaired working memory via lateral habenula Kv7.2 subunit-containing M-channels in experimental parkinsonism.

  2025cites this paper
• Small molecule inhibits KCNQ channels with a non-blocking mechanism

  2025cites this paper
• Pharmacological and electrophysiological characterization of the novel Kv7 channel inhibitor racecadotril in Parkinson's disease.

  2025cites this paper
• Lead Optimization of Positive Allosteric KV7.2/3 Channel Modulators toward Improved Balance of Lipophilicity and Aqueous Solubility.

  2025cites this paper
• Therapeutic role of voltage-gated potassium channels in age-related neurodegenerative diseases

  2024cites this paper
• Modulation of Kv7 Channel Currents by Echinocystic Acid

  2023influential citation
• Ligand activation mechanisms of human KCNQ2 channel

  2023cites this paper
• Potassium Channels in Parkinson’s Disease: Potential Roles in Its Pathogenesis and Innovative Molecular Targets for Treatment

  2023influential citation
• Effects of potassium channel modulators on the responses of mammalian slowly adapting mechanoreceptors

  2022cites this paper
• Kv7 channel antagonists block glycine receptors

  2022cites this paper
• Behavior of KCNQ Channels in Neural Plasticity and Motor Disorders

  2022influential citation
• A new K+channel-independent mechanism is involved in the antioxidant effect of XE-991 in an in vitro model of glucose metabolism impairment: implications for Alzheimer’s disease

  2022cites this paper
• Kv7 Channels and Excitability Disorders.

  2021cites this paper
• The mechanism behind activation of the Nod-like receptor family protein 3 inflammasome in Parkinson’s disease

  2021cites this paper
• Drug repositioning based on network-specific core genes identifies potential drugs for the treatment of autism spectrum disorder in children

  2021cites this paper
• Ligand modulation of KCNQ-encoded (KV7) potassium channels in the heart and nervous system.

  2021cites this paper
• Physiology and Therapeutic Potential of SK, H, and M Medium AfterHyperPolarization Ion Channels

  2021cites this paper
• Chemical modulation of Kv7 potassium channels.

  2021cites this paper
• The Role of Kv7.2 in Neurodevelopment: Insights and Gaps in Our Understanding

  2020cites this paper
• Kv7.2 subunit-containing M-type potassium channels in the lateral habenula are involved in the regulation of working memory in parkinsonian rats.

  2020cites this paper
• An anthrone-based Kv7.2/7.3 channel blocker with improved properties for the investigation of psychiatric and neurodegenerative disorders.

  2019cites this paper
• Iron‐induced oxidative stress contributes to &agr;‐synuclein phosphorylation and up‐regulation via polo‐like kinase 2 and casein kinase 2

  2019cites this paper
• Neuroprotective Effects of Brain-Gut Peptides: A Potential Therapy for Parkinson’s Disease

  2019cites this paper